Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation
Open Access
- 7 May 2025
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-13
Abstract
Elevated inflammation in the midbrain of ~45% of people with schizophrenia may relate to altered trophic support for neurons. Dopamine neurons require trophic support from Brain-Derived Neurotrophic Factor (BDNF), that signals via the full-length Tropomyosin kinase B receptor (TrkBTK+). The truncated BDNF receptor (TrkBTK-) and the apoptosis-related p75 receptor may counteract the effects of BDNF. We hypothesised that transcriptional changes in either BDNF, and/or a transcription factor critical for the maintenance of dopamine neurons (Nuclear Receptor Related-1 protein; NURR1), and/or BDNF receptors – TrkB (TK+ or TK-) and p75, would be found in the post-mortem schizophrenia midbrain, particularly in schizophrenia cases defined as “high inflammation”. The neuroinflammatory status was delineated based on elevated expression levels of a combination of pro-inflammatory transcripts (SERPINA3, IL6, IL1β and TNFα) and defined as a subgroup (46%) by 2-step recursive clustering. Using RT-qPCR, mRNA levels of NURR1, BDNF, TrkB and p75 was quantified in schizophrenia (n = 65) and control (n = 64) ventral mesencephalon. We found significant decreases in BDNF, TrkBTK+ and NURR1 (14–18%) and increases in TrkBTK- and p75 (18–35%) mRNA levels in schizophrenia compared to controls (all p < 0.05), with exacerbation of changes identified in high inflammation schizophrenia. To determine whether these changes would be consistent with resulting from chronic antipsychotic treatment, we treated healthy adult rats with antipsychotics (haloperidol and risperidone) for 7 months and found all transcripts to be unaltered compared to control rats. SnRNAseq of human midbrain showed that p75 receptor mRNA is primarily localised in oligodendrocytes and pan-TrkB mRNA is in both neurons and astrocytes. We confirmed that p75 was localised to oligodendrocyte-like cells by immunohistochemistry. Altogether, we find transcriptional evidence of reduced trophic support in schizophrenia midbrain and suggest that this may directly impact dopamine neuron health, particularly when neuroinflammation is also present.Keywords
All Related Versions
Funding Information
- NSW Ministry of Health
- Department of Health | National Health and Medical Research Council
This publication has 116 references indexed in Scilit:
- Correlation of BDNF, VEGF, TNF‐α, and S100B with cognitive impairments in chronic, medicated schizophrenia patientsNeuropsychopharmacology Reports, 2022
- The Impact of Oxidative Stress on Dopaminergic Neurotransmission2014
- BDNF and Synaptic Plasticity, Cognitive Function, and Dysfunction2014
- CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITSDepression and Anxiety, 2013
- Brain‐derived neurotrophic factor and the development of structural neuronal connectivityDevelopmental Neurobiology, 2010
- Nurr1 in Parkinson's disease and related disordersJournal of Comparative Neurology, 2005
- White Matter Changes in SchizophreniaArchives of General Psychiatry, 2003
- Age‐related decreases in Nurr1 immunoreactivity in the human substantia nigraJournal of Comparative Neurology, 2002
- Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administrationJournal of Neuroscience Research, 2000
- Alterations in Nigrostriatal Dopaminergic Function within BDNF Mutant MiceExperimental Neurology, 1999